QuidelOrtho Corp (QDEL) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
9975 SUMMERS RIDGE ROAD SAN DIEGO, CA 92121 |
| State of Incorp. | |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2835 - In Vitro and In Vivo Diagnostic Substances (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | |||
|---|---|---|---|---|---|
| ASSETS | |||||
| Current Assets | |||||
| Cash, cash equivalents, and short-term investments | 167 | 345 | |||
| Cash and cash equivalent | 119 | 293 | |||
| Short-term investments | 48 | 52 | |||
| Receivables | 442 | 403 | |||
| Inventory, net of allowances, customer advances and progress billings | 578 | 524 | |||
| Inventory | 578 | 524 | |||
| Prepaid expense | 67 | 97 | |||
| Derivative instruments and hedges, assets | 7 | 22 | |||
| Asset, held-for-sale, not part of disposal group | |||||
| Other current assets | 3 | 1 | |||
| Other undisclosed current assets | 46 | 183 | |||
| Total current assets: | 1,311 | 1,575 | |||
| Noncurrent Assets | |||||
| Inventory, Noncurrent | |||||
| Operating lease, right-of-use asset | 170 | 181 | |||
| Property, plant and equipment | 1,444 | 1,339 | |||
| Long-term investments and receivables | 7 | 21 | |||
| Long-term investments | 7 | 21 | |||
| Intangible assets, net (including goodwill) | 5,426 | 5,601 | |||
| Goodwill | 2,492 | 2,477 | |||
| Intangible assets, net (excluding goodwill) | 2,934 | 3,124 | |||
| Restricted cash and investments | |||||
| Deferred income tax assets | 26 | 16 | |||
| Other noncurrent assets | 180 | 123 | |||
| Other undisclosed noncurrent assets | |||||
| Total noncurrent assets: | 7,253 | 7,281 | |||
| TOTAL ASSETS: | 8,563 | 8,856 | |||
| LIABILITIES AND EQUITY | |||||
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 391 | 474 | |||
| Accounts payable | 295 | 283 | |||
| Accrued liabilities | 96 | 191 | |||
| Debt | 140 | 208 | |||
| Other liabilities | 303 | 325 | |||
| Total current liabilities: | 834 | 1,007 | |||
| Noncurrent Liabilities | |||||
| Long-term debt and lease obligation, including: | 2,275 | 2 | |||
| Long-term debt, excluding current maturities | 0 | 1 | |||
| Finance lease, liability | 0 | 1 | |||
| Other undisclosed long-term debt and lease obligation | 2,274 | ||||
| Liabilities, other than long-term debt | 449 | 483 | |||
| Deferred income tax liabilities | 192 | 213 | |||
| Other liabilities | 84 | 84 | |||
| Operating lease, liability | 173 | 186 | |||
| Other undisclosed noncurrent liabilities | 2,429 | ||||
| Total noncurrent liabilities: | 2,723 | 2,914 | |||
| Total liabilities: | 3,557 | 3,921 | |||
| Equity | |||||
| Equity, attributable to parent | 5,006 | 4,935 | |||
| Common stock | 0 | ||||
| Additional paid in capital | 2,848 | 2,804 | |||
| Accumulated other comprehensive loss | (30) | (68) | |||
| Retained earnings | 2,188 | 2,198 | |||
| Other undisclosed equity | (5,036) | (5,002) | |||
| Total equity: | (30) | (68) | |||
| Other undisclosed liabilities and equity | 5,036 | 5,002 | |||
| TOTAL LIABILITIES AND EQUITY: | 8,563 | 8,856 | |||
Income Statement (P&L) ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Revenues | 2,998 | 3,266 | ||
| Cost of revenue (Cost of Product and Service Sold) | (1,503) | (1,330) | ||
| Gross profit: | 1,494 | 1,936 | ||
| Operating expenses | (1,151) | (960) | ||
| Other undisclosed operating loss | (205) | (133) | ||
| Operating income (loss): | 139 | 844 | ||
| Nonoperating expense (Other Nonoperating expense) | (21) | (8) | ||
| Interest and debt expense | (3) | (26) | ||
| Income (loss) from continuing operations before equity method investments, income taxes: | 115 | 810 | ||
| Income from equity method investments | ||||
| Other undisclosed loss from continuing operations before income taxes | (144) | (74) | ||
| Income (loss) from continuing operations before income taxes: | (29) | 736 | ||
| Income tax expense (benefit) | 19 | (187) | ||
| Net income (loss) available to common stockholders, diluted: | (10) | 549 | ||
Comprehensive Income ($ in millions)
| 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|
| Net income (loss): | (10) | 549 | ||
| Other comprehensive income | ||||
| Comprehensive income (loss): | (10) | 549 | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 38 | (68) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 28 | 481 | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.